Related Experiment Video
Updated: May 14, 2026

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
Garland Rolling Circle Amplification Mediated Self-Priming Extension Strategy for Sensitive and Label-Free
1Department of Operation Room, The First People's Hospital of Linping District, Hangzhou City, Zhejiang Province 311100, P. R. China.
Abstract:
Early and accurate detection of Pseudomonas aeruginosa (P. aeruginosa) is critically important in perioperative care to prevent severe healthcare-associated infections and guide timely antimicrobial intervention. Herein, we report a novel biosensing strategy for sensitive and label-free detection of P. aeruginosa by integrating F23 aptamer-mediated target recognition, garland rolling circle amplification (RCA)-triggered self-priming extension, and SYBR Green I (SG-I)-based fluorescence readout. The capture probe, comprising the F23 aptamer and a primer strand immobilized on magnetic nanoparticles, specifically recognizes P. aeruginosa and releases the primer to initiate dumbbell probe circularization and subsequent RCA. The resulting RCA products are cleaved by a nicking endonuclease to generate fragmented DNA, which then hybridizes with a hairpin probe to prime cyclic self-extension reactions, producing abundant double-stranded DNA for SG-I intercalation and fluorescence enhancement. Under optimized conditions, the proposed method achieves a detection limit as low as 2.3 CFU/mL with a wide linear range from 10 to 106 CFU/mL. The assay exhibits excellent specificity against non-target bacteria, robust stability during storage, and satisfactory anti-interference capability in complex clinical matrices. Validation using clinical samples demonstrates excellent agreement with the gold-standard colony counting method while reducing the assay time to less than 2.5 h without requiring nucleic acid extraction or thermal cycling. With its label-free design, isothermal amplification, and operational simplicity, this strategy holds great promise for point-of-care testing in perioperative settings and can be readily adapted for detecting other pathogens by substituting the corresponding aptamer.
Insights
A new biosensing strategy enables sensitive, label-free detection of Pseudomonas aeruginosa (P. aeruginosa) using aptamers and isothermal amplification. This rapid assay is promising for perioperative point-of-care testing to combat healthcare-associated infections.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Infectious Disease Detection
Background:
- Early detection of Pseudomonas aeruginosa (P. aeruginosa) is crucial in perioperative care to prevent severe infections.
- Current methods can be time-consuming and require complex procedures like nucleic acid extraction.
Purpose of the Study:
- To develop a novel, sensitive, and label-free biosensing strategy for rapid P. aeruginosa detection.
- To enable timely antimicrobial intervention and improve patient outcomes in perioperative settings.
Main Methods:
- Integration of F23 aptamer for target recognition, rolling circle amplification (RCA) for signal amplification, and SYBR Green I for fluorescence readout.
- Utilized magnetic nanoparticles for probe immobilization and a nicking endonuclease for enhanced DNA fragmentation and subsequent amplification.
- Isothermal amplification and label-free detection approach.
Main Results:
- Achieved a low detection limit of 2.3 CFU/mL for P. aeruginosa with a wide linear range (10-10^6 CFU/mL).
- Demonstrated excellent specificity, stability, and anti-interference capabilities in clinical samples.
- Validated results against the gold-standard method with reduced assay time (<2.5 hours) and without nucleic acid extraction or thermal cycling.
Conclusions:
- The proposed aptamer-based biosensing strategy offers a rapid, sensitive, and simple method for P. aeruginosa detection.
- This approach holds significant potential for point-of-care testing in perioperative settings.
- The platform is adaptable for detecting other bacterial pathogens by modifying the aptamer component.

